Spots Global Cancer Trial Database for anaplastic lymphoma kinase positive (alk +) anaplastic large cell lymphoma
Every month we try and update this database with for anaplastic lymphoma kinase positive (alk +) anaplastic large cell lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors | NCT04260009 | Anaplastic Lymp... Inflammatory My... Solid Tumors | Brigatinib Brigatinib AAF | 1 Year - 25 Years | Takeda |